CorMedix

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$128,615
$104,275
$39,736
$39,081
Gross Profit
107,308
93,080
37,874
37,484
EBITDA
66,478
57,314
20,519
20,815
EBIT
55,606
53,524
20,356
20,653
Net Income
14,020
108,562
19,827
20,643
Net Change In Cash
128,615
104,275
39,736
39,081
Free Cash Flow
94,416
30,350
29,967
19,726
Cash
145,825
48,493
159,308
66,285
Basic Shares
93,919
86,214
71,918
68,975

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$311,709
$43,472
$0
$65
Gross Profit
275,748
40,281
-205
61
EBITDA
165,128
-18,978
-46,234
-30,051
EBIT
150,141
-19,288
-46,304
-30,260
Net Income
163,055
-17,930
-46,339
-29,701
Net Change In Cash
311,709
43,472
0
65
Free Cash Flow
172,786
-50,730
-38,736
-24,576
Cash
145,825
40,650
43,642
43,374
Basic Shares
80,308
58,871
50,902
40,274

Earnings Calls

QuarterEPS
2025-12-31
$0.16
2025-09-30
$1.40
2025-06-30
$0.28
2025-03-31
$0.29